Inflammatory Markers and Outcomes in Cardiovascular Disease

article has not abstract

Vyšlo v časopise: Inflammatory Markers and Outcomes in Cardiovascular Disease. PLoS Med 6(9): e32767. doi:10.1371/journal.pmed.1000147
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000147

Souhrn

article has not abstract

Zdroje

1. TedguiA

MallatZ

2006 Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev 86 515 581

2. Ridker PMBJ

CookNR

RifaiN

2003 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107 391 397

3. SabatineMS

MorrowDA

JablonskiKA

RiceMM

WarnicaJW

2007 Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115 1528 1536

4. Di NapoliM

SchwaningerM

CappelliR

CeccarelliE

Di GianfilippoG

2005 Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36 1316 1329

5. DaneshJ

WheelerJG

HirschfieldGM

EdaS

EiriksdottirG

2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N EnglJ Med 350 1387 1389

6. CookNR

2007 Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115 928 935

7. ZetheliusB

BerglundL

SundströmJ

IngelssonE

BasuS

2008 Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358 2107 2116

8. RidkerPM

DanielsonE

FonsecaFA

GenestJ

GottoAMJr

2008 Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 2195 2207

9. SattarN

MurrayH

WelshP

BlauwGJ

BuckleyBM

2009 PLoS Med 6(6) e99 Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? doi:10.1371/journal.pmed.1000099

10. WhiteleyW

JacksonC

LewisS

LoweG

RumleyA

2009 Inflammatory markers and poor outcome after stroke: A prospective cohort study and systematic review of interleukin 6. PLoS Med 6(8) e145 doi:10.1371/journal.pmed.1000145

11. AudebertHJ

RottMM

EckT

HaberlH

2004 Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35 2128 2133